Becker's Clinical Quality & Infection Control

Becker's Infection Control & Clinical Quality January 2017

Issue link: https://beckershealthcare.uberflip.com/i/774606

Contents of this Issue

Navigation

Page 8 of 47

In Peer Review Abstract Details 39% drop in C. diff infection rates in 6 month controlled study with 85% of discharges treated APIC Conference Poster/June 2016 (Folkert, Mayo Clinic Rochester) Clinical Effectiveness Peer Reviewed Outcome Studies 46% reduction in Class I SSIs, $478,055 saved AJIC/February 2016 (Catalanotti, Lowell General Hospital) 87% reduction in ICU VRE infection rates, combined VRE+MRSA+C. diff infection rates reduced 29% facility wide and 61% in ICU, 390 bed days generated, $730,000 saved AJIC/October 2015 (Vianna, South Seminole Hospital - Orlando Health) 100% reduction in total joint SSIs and $290,990 saved in 12 months AJIC/September 2015 (Fornwalt, Trinity Medical Center) 57% reduction in C. diff infection rates in an LTAC AJIC/September 2015 (Miller) 70% reduction in ICU C. diff infection rates AJIC/September 2015 (Nagaraja, Westchester Medical Center) 20% reduction in C. diff + MDRO infection rates, 22% of discharge rooms treated AJIC/June 2014 (Haas, Westchester Medical Center) 57% reduction in MRSA infection rates aer 18 months JIP/June 2013 (Simmons, Moses Cone Health) 53% reduction in C. diff infection rates aer 12 months AJIC/May 2013 (Levin, Cooley Dickinson Hospital) Environmental Peer Reviewed Environmental Studies Elimination of Ebola (>4 log) and Anthrax (>3 log), >6-log reduction of MRSA, CRE, MDR-A. baumanii, and more SAJID/April 2016 (Stibich, CNB/CSIC-Spain & TXBiomed Biosafety Level 4 Lab-US) 5 log reduction of MRSA, VRE, Acinetobacter and CRE in 10 minutes AJIC/March 2016 (Hosein, Queen's Hospital - Romford UK) Significant reductions in burn unit ORs and patient room contamination, longest duration with no cases of hospital acquired C. diff infections in burn ICU in 2 years BURNS/In Press November 2016 (Green, San Antonio Military Medical Center) Xenex effective even in absence of manual cleaning AJIC/April 2015 (Jinadatha, Central Texas VA Health Care System) • 99.6% reduction in real-world hospital bioburden • Xenex efficacy not affected by shading, pathogen concentration, or surface protein load ICHE/January 2015 (Nerandzic, Louis Stokes Cleveland VA Medical Center) Bleach removed 70% of C. diff spores while no-bleach clean plus Xenex removed 95% JMM/January 2015 (Ghantoji, MD Anderson Cancer Center) • 7X more effective than traditional cleaning • 16X more effective at deactivating MRSA • 23% faster than traditional cleaning BMC Infectious Diseases/April 2014 (Jinadatha, Central Texas VA Health Care System) Xenex eliminated all VRE from the environment ICHE/March 2011 (Stibich, MD Anderson Cancer Center) HCAHPS Improvement Peer Reviewed Published Study HCAHPS score increased from 52nd percentile to 78th percentile (10% increase) for 3 qtrs aer Xenex patient awareness campaign Risk Management and Healthcare Policy/January 2014 (Fornwalt, Trinity Medical Center) RESULTS JOURNAL/DATE (AUTHOR, LOCATION) PEER REVIEWED PUBLISHED CLINICAL OUTCOME AND ENVIRONMENTAL STUDIES ALWAYS ASK UV DISINFECTION VENDORS FOR ALL OF THEIR PEER REVIEWED PUBLISHED CLINICAL OUTCOME STUDIES. xenex.com/studies | 888-299-1914

Articles in this issue

Links on this page

view archives of Becker's Clinical Quality & Infection Control - Becker's Infection Control & Clinical Quality January 2017